Emily Hinchcliff

1.8k total citations
59 papers, 722 citations indexed

About

Emily Hinchcliff is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Emily Hinchcliff has authored 59 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Reproductive Medicine, 24 papers in Oncology and 24 papers in Obstetrics and Gynecology. Recurrent topics in Emily Hinchcliff's work include Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Emily Hinchcliff is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (23 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Emily Hinchcliff collaborates with scholars based in United States, Netherlands and Germany. Emily Hinchcliff's co-authors include Alexander Melamed, J. Alejandro Rauh‐Hain, Marcela G. del Carmen, Michael G. Muto, Elisabeth Diver, Bradley J. Quade, Allison Gockley, Titilope Oduyebo, Sarah Feldman and Karen H. Lu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and American Journal of Obstetrics and Gynecology.

In The Last Decade

Emily Hinchcliff

49 papers receiving 707 citations

Peers

Emily Hinchcliff

SURGE

ONCOL

Fuat Demirkıran Türkiye

Macit Arvas Türkiye

Francesca Ciccarone Italy

Shannon Salvador Canada

Kristin Bixel United States

Tugan Beşe Türkiye

Antonella Villa Italy

Maria-Pilar Barretina-Ginesta Spain

Tomoyuki Ichimura Japan

Valérie Dubé Canada

Fuat Demirkıran Türkiye

Emily Hinchcliff

451 ×1.2

436 ×1.2

166 ×0.9

SURGE

132 ×0.9

ONCOL

97 ×1.2

Citations per year, relative to Emily Hinchcliff Emily Hinchcliff (= 1×) peers Fuat Demirkıran

Countries citing papers authored by Emily Hinchcliff

Since Specialization

Citations

This map shows the geographic impact of Emily Hinchcliff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Hinchcliff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Hinchcliff more than expected).

Fields of papers citing papers by Emily Hinchcliff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Hinchcliff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Hinchcliff. The network helps show where Emily Hinchcliff may publish in the future.

Co-authorship network of co-authors of Emily Hinchcliff

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Hinchcliff. A scholar is included among the top collaborators of Emily Hinchcliff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Hinchcliff. Emily Hinchcliff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benjamin, Amy, Daniela Matei, Emily Hinchcliff, et al.. (2025). Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer. Gynecologic Oncology. 199. 116–123.

Smith, Sionagh H., et al.. (2025). EML4::NTRK3 Rearranged Ovarian Neoplasm: Case Report and Literature Review. International Journal of Gynecological Pathology. 45(2). 170–174.

Foley, Olivia, et al.. (2023). Advances in Cervical Cancer. 3(1). 55–66.

Rauh‐Hain, J. Alejandro, Ross Harrison, Jeffrey How, et al.. (2023). Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report. SHILAP Revista de lepidopterología. 16(1). 279–284. 1 indexed citations

Roque, Dario R., et al.. (2022). Surgical Training in Gynecologic Oncology: A Sea Change. Journal of Gynecologic Surgery. 38(6). 393–396. 1 indexed citations

Hinchcliff, Emily, et al.. (2020). Developmental sacral morphology: MR study from infancy to skeletal maturity. European Spine Journal. 29(5). 1141–1146. 5 indexed citations

Kurnit, Katherine C., et al.. (2020). PARP inhibition in the ovarian cancer patient: Current approvals and future directions. Pharmacology & Therapeutics. 213. 107588–107588. 12 indexed citations

Hinchcliff, Emily, Jillian R. Gunther, Brian K. Bednarski, et al.. (2020). A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. Journal of Cancer Education. 37(3). 615–620.

Hinchcliff, Emily, Erica M. Bednar, Karen H. Lu, & J. Alejandro Rauh‐Hain. (2019). Disparities in gynecologic cancer genetics evaluation. Gynecologic Oncology. 153(1). 184–191. 56 indexed citations

10.

Hinchcliff, Emily, et al.. (2019). Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies. International Journal of Gynecological Cancer. 29(5). 956–968. 3 indexed citations

11.

Hinchcliff, Emily, Cherie Paquette, Jason Roszik, et al.. (2019). Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer Immunology Immunotherapy. 68(9). 1515–1526. 14 indexed citations

12.

Hinchcliff, Emily, et al.. (2018). Visuospatial Aptitude Testing Differentially Predicts Simulated Surgical Skill. Journal of Minimally Invasive Gynecology. 25(6). 1044–1050. 6 indexed citations

13.

Hinchcliff, Emily, Alexander Melamed, Amy Bregar, et al.. (2017). Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer. Gynecologic Oncology. 148(1). 168–173. 14 indexed citations

14.

Melamed, Alexander, Emily Hinchcliff, Joel Clemmer, et al.. (2016). Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States. Gynecologic Oncology. 143(2). 236–240. 82 indexed citations

15.

Hinchcliff, Emily, Katharine M. Esselen, Jaclyn C. Watkins, et al.. (2016). The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma. Journal of Minimally Invasive Gynecology. 23(4). 567–572. 42 indexed citations

16.

Hinchcliff, Emily & Sarah L. Cohen. (2015). Laparoscopic Hysterectomy for Uterine Fibroids. Clinical Obstetrics & Gynecology. 59(1). 66–72. 4 indexed citations

17.

Melamed, Alexander, Emily Hinchcliff, Michael J. Worley, et al.. (2015). Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer. Annals of Surgical Oncology. 23(1). 178–185. 46 indexed citations

18.

Mahdi, Haider, Allison Gockley, Jessica Marquard, et al.. (2015). Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer. Gynecologic Oncology. 139(3). 407–412. 14 indexed citations

19.

Rauh‐Hain, Jose Alejandro, Olivia Foley, Rachel M. Clark, et al.. (2014). Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. American Journal of Obstetrics and Gynecology. 212(5). 600.e1–600.e8. 3 indexed citations

20.

Oduyebo, Titilope, Emily E. Meserve, Michael A. Seidman, et al.. (2013). The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecologic Oncology. 132(2). 360–365. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact